APVO icon

Aptevo Therapeutics
APVO

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $209K invested in Aptevo Therapeutics in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$88.1K
2
+$49.7K
3
+$19.5K
4
Morgan Stanley
Morgan Stanley
New York
+$16.9K
5
UBS Group
UBS Group
Switzerland
+$3.38K

Top Sellers

1
-$168K
2
-$20.1K
3
-$7.85K
4
Renaissance Technologies
Renaissance Technologies
New York
-$6.58K
5
TSS
Two Sigma Securities
New York
-$5.04K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$93K
2
$53K
3
$19.5K
4
$17.5K
5
$16.9K
6
$4.68K
7
$3.38K
8
$565
9
$103
10
$22
11
$17
12
$4
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–